A nasal spray formulation of bumetanide has been shown to be safe and effective in a new study and could ultimately prevent ...
A study conducted bà Cattolica in Rome and the Fondazione Policlinico Universitario Agostino Gemelli IRCCS has uncovered a ...
FDA reported that, for now, companies can continue to market OTC monograph drug products containing oral phenylephrine as a ...
A curious link between Alzheimer's and insulin resistance is now so well-established, the neurodegenerative disease is ...
A future treatment for Alzheimer disease may involve a nasal spray. Researchers at Università Cattolica and Fondazione ...
The Federal Government is funding a national Take Home Naloxone (THN) program that makes the life-saving medication available ...
New research highlights nasal spray drug’s potential to counter Alzheimer’s by targeting brain enzyme dysfunction.
Italian researchers have developed a nasal spray showing promise in slowing Alzheimer's progression. Tests on mice with ...
Neffy, a new epinephrine nasal spray, offers a less invasive option for treating allergic reactions. Learn about its benefits ...
Semax, a synthetic analogue of the adrenocorticotropic hormone (ACTH), has been extensively researched for its neuroprotective and neuroregenerative properties. Developed in the late 1980s by Russian ...
A nasal spray drug can counteract the cognitive decline and brain damage typical of Alzheimer's disease in animal models.